AseptiScope
San Diego, US · Founded 2016 · Delaware corporation
AseptiScope develops infection prevention technology for healthcare systems, with a flagship product, the DiskCover System, that provides an automated, touch-free barrier to address stethoscope contamination. The company serves clinicians and healthcare systems, with additional infection prevention products in development.
Founders & leadership
KM
Kelly M. PowersNamed on SEC filing
AS
Alan S. Maisel, MDNamed on SEC filing
WF
William Frank Peacock, MDNamed on SEC filing
SW
Scott W. MaderNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10.1M disclosed across 3 rounds · 2018–2020
▶$8.1MraisedJan 2021 · 103 investors · Other Health CareRule 506(b)
▶$8.1MraisedJan 2021 · 103 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott W. MaderExecutive Officer, Director
- Alan S. Maisel, MDExecutive Officer, Director
- William Frank Peacock, MDExecutive Officer, Director
- Kelly M. PowersExecutive Officer, Director
- Offering amount
- $8.7M
- Amount sold
- $8.1M
- Sales commissions
- $405.3K
- Placement agents
- Arcadia Securities, LLC
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$595KraisedApr 2020 · 17 investors · Other Health CareRule 506(b)
▶$595KraisedApr 2020 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott W. MaderExecutive Officer, Director
- William Frank Peacock, MDExecutive Officer, Director
- Kelly M. PowersExecutive Officer, Director
- Alan S. Maisel, MDExecutive Officer, Director
- Offering amount
- $1000K
- Amount sold
- $595K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.4MraisedJan 2020 · 42 investors · Other Health CareRule 506(b)
▶$1.4MraisedJan 2020 · 42 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kelly M. PowersExecutive Officer, Director
- Alan S. Maisel, MDExecutive Officer, Director
- William Frank Peacock, MDExecutive Officer, Director
- Scott W. MaderExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.4M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapOlympusamerica3 shared keywordsOlympus develops medical technologies and solutions for detecting and treating disease. The company serves healthcare systems, patients, and medical professionals globally.
Boston Scientific3 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies competing with AseptiScope for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AseptiScope do?
- AseptiScope develops infection prevention technology for healthcare systems, with a flagship product, the DiskCover System, that provides an automated, touch-free barrier to address stethoscope contamination. The company serves clinicians and healthcare systems, with additional infection prevention products in development.
- How much funding has AseptiScope raised?
- AseptiScope has disclosed $10.1M raised across 3 rounds.
- Where is AseptiScope headquartered?
- AseptiScope is headquartered in San Diego, US.